Eisai Co (FRA:EIIA) Cyclically Adjusted Revenue per Share: €8.43 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EIIA Eisai Co Ltd FRA:EIIA
78 GF Score
Price €6.15
GF Value €7.28
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Eisai Co Cyclically Adjusted Revenue per Share?

Eisai Co FRA:EIIA -0.81% 78 Cyclically Adjusted Revenue per Share is €8.43 as of Mar. 2026. GuruFocus rates FRA:EIIA with a GF Score™ of 78/100 and a GF Value™ of €7.28 (Modestly Undervalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Eisai Co's adjusted revenue per share for the three months ended in Mar. 2026 was €0.993. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €8.43 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Eisai Co's average Cyclically Adjusted Revenue Growth Rate was -6.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -5.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -2.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Eisai Co was 5.00% per year. The lowest was -5.00% per year. And the median was 1.95% per year.

As of today (2026-08-15), Eisai Co's current stock price is €6.15. Eisai Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €8.43. Eisai Co's Cyclically Adjusted PS Ratio of today is 0.73.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Eisai Co was 1.65. The lowest was 0.50. And the median was 0.97.


Eisai Co  (FRA:EIIA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Eisai Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6.15/8.43
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Eisai Co was 1.65. The lowest was 0.50. And the median was 0.97.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Eisai Co Cyclically Adjusted Revenue per Share Related Terms


Eisai Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Eisai Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co Cyclically Adjusted Revenue per Share Chart

Eisai Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 12.67 10.74 10.29 8.43

Eisai Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.29 9.70 9.24 8.64 8.43

FRA:EIIA vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's Cyclically Adjusted PS Ratio falls into.


FRA:EIIA
78GF Score
Eisai Co Ltd FRA:EIIA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eisai Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eisai Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.993/112.7000*112.7000
=0.993

Current CPI (Mar. 2026) = 112.7000.

Eisai Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 4.043 98.100 4.645
201609 4.063 98.000 4.672
201612 3.975 98.400 4.553
201703 3.754 98.100 4.313
201706 3.974 98.500 4.547
201709 3.787 98.800 4.320
201712 4.042 99.400 4.583
201803 4.282 99.200 4.865
201806 4.160 99.200 4.726
201809 4.183 99.900 4.719
201812 4.294 99.700 4.854
201903 4.872 99.700 5.507
201906 4.399 99.800 4.968
201909 4.279 100.100 4.818
201912 5.376 100.500 6.029
202003 6.138 100.300 6.897
202006 4.767 99.900 5.378
202009 4.248 99.900 4.792
202012 5.007 99.300 5.683
202103 3.978 99.900 4.488
202106 1.308 99.500 1.482
202109 4.399 100.100 4.953
202112 1.376 100.100 1.549
202203 1.275 101.100 1.421
202206 1.134 101.800 1.255
202209 1.071 103.100 1.171
202212 1.144 104.100 1.239
202303 1.207 104.400 1.303
202306 1.121 105.200 1.201
202309 0.976 106.200 1.036
202312 0.986 106.800 1.040
202403 1.020 107.200 1.072
202406 0.971 108.200 1.011
202409 1.084 108.900 1.122
202412 1.181 110.700 1.202
202503 1.030 111.100 1.045
202506 1.079 111.700 1.089
202509 1.009 112.000 1.015
202512 1.068 113.000 1.065
202603 0.993 112.700 0.993

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €8.43 mean?
Eisai Co (FRA:EIIA) has a Cyclically Adjusted Revenue per Share of €8.43 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Eisai Co and its competitors.
Is Eisai Co's Cyclically Adjusted Revenue per Share too high?
Eisai Co's current Cyclically Adjusted Revenue per Share is €8.43. Overall, Eisai Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's Cyclically Adjusted Revenue per Share compare to ZTS?
Eisai Co's Cyclically Adjusted Revenue per Share of €8.43 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Eisai Co and its competitors. Eisai Co's current Cyclically Adjusted Revenue per Share is €8.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (FRA:EIIA) is currently considered Modestly Undervalued. The stock's GF Value™ is €7.28, compared to a current price of €6.15 — trading 15.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €8.43. Eisai Co's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Eisai Co (FRA:EIIA), the current Cyclically Adjusted Revenue per Share is €8.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eisai Co (FRA:EIIA) Overvalued in 2026?

Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued. The current stock price of €6.15 is trading 15.5% below its estimated GF Value™ of €7.28. GuruFocus considers Eisai Co to be Modestly Undervalued.

Key valuation signals for FRA:EIIA:

  • Cyclically Adjusted Revenue per Share: €8.43
  • GF Value™: €7.28 vs. price of €6.15 (15.5% below fair value)
  • GF Score™: 78/100 with 8 warning signs

No single metric tells the full story. See the FRA:EIIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eisai Co Business Description

Address 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
78GF Score

Get the complete analysis for FRA:EIIA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.15
Price
€7.28
GF Value